BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 14691170)

  • 21. Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab.
    Zou J; Rudwaleit M; Brandt J; Thiel A; Braun J; Sieper J
    Arthritis Rheum; 2003 Mar; 48(3):780-90. PubMed ID: 12632433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunomodulatory effects of Longdan Xiegan Tang on CD4+/CD8+ T cells and associated inflammatory cytokines in rats with experimental autoimmune uveitis.
    Tang K; Guo D; Zhang L; Guo J; Zheng F; Si J; Bi H
    Mol Med Rep; 2016 Sep; 14(3):2746-54. PubMed ID: 27485320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.
    Berner B; Akça D; Jung T; Muller GA; Reuss-Borst MA
    J Rheumatol; 2000 May; 27(5):1128-35. PubMed ID: 10813277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dominant role for TL1A/DR3 pathway in IL-12 plus IL-18-induced IFN-gamma production by peripheral blood and mucosal CCR9+ T lymphocytes.
    Papadakis KA; Zhu D; Prehn JL; Landers C; Avanesyan A; Lafkas G; Targan SR
    J Immunol; 2005 Apr; 174(8):4985-90. PubMed ID: 15814728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Staphylococcal enterotoxin B is involved in aggravation and recurrence of murine experimental autoimmune uveoretinitis via Vbeta8+CD4+ T cells.
    Kohno H; Sakai T; Tsuneoka H; Imanishi K; Saito S
    Exp Eye Res; 2009 Oct; 89(4):486-93. PubMed ID: 19523946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions.
    Balashov KE; Rottman JB; Weiner HL; Hancock WW
    Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6873-8. PubMed ID: 10359806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune responses to retinal self-antigens in CD25(+)CD4(+) regulatory T-cell-depleted mice.
    Takeuchi M; Keino H; Kezuka T; Usui M; Taguchi O
    Invest Ophthalmol Vis Sci; 2004 Jun; 45(6):1879-86. PubMed ID: 15161853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of therapy with chimeric monoclonal tumour necrosis factor-alpha antibodies on intracellular cytokine profiles of T lymphocytes and monocytes in rheumatoid arthritis patients.
    Schuerwegh AJ; Van Offel JF; Stevens WJ; Bridts CH; De Clerck LS
    Rheumatology (Oxford); 2003 Apr; 42(4):541-8. PubMed ID: 12649401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experimental autoimmune uveoretinitis: a model system for immunointervention: a review.
    Forrester JV; Liversidge J; Dua HS; Dick A; Harper F; McMenamin PG
    Curr Eye Res; 1992; 11 Suppl():33-40. PubMed ID: 1358557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamic T-lymphocyte chemokine receptor expression induced by interferon-beta therapy in multiple sclerosis.
    Krakauer M; Sorensen PS; Khademi M; Olsson T; Sellebjerg F
    Scand J Immunol; 2006 Aug; 64(2):155-63. PubMed ID: 16867161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-inflammatory effect of retinoic acid on experimental autoimmune uveoretinitis.
    Keino H; Watanabe T; Sato Y; Okada AA
    Br J Ophthalmol; 2010 Jun; 94(6):802-7. PubMed ID: 19965837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Type 1 chemokine receptor expression in Chagas' disease correlates with morbidity in cardiac patients.
    Gomes JA; Bahia-Oliveira LM; Rocha MO; Busek SC; Teixeira MM; Silva JS; Correa-Oliveira R
    Infect Immun; 2005 Dec; 73(12):7960-6. PubMed ID: 16299288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contribution of CD4+CD25+ T cells to the regression phase of experimental autoimmune uveoretinitis.
    Sun M; Yang P; Du L; Zhou H; Ren X; Kijlstra A
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):383-9. PubMed ID: 19696173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abnormal expression of intracellular cytokines and chemokine receptors in peripheral blood T lymphocytes from patients with systemic sclerosis.
    Fujii H; Hasegawa M; Takehara K; Mukaida N; Sato S
    Clin Exp Immunol; 2002 Dec; 130(3):548-56. PubMed ID: 12452848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulation of CXCR6 and CXCR3 in lymphocytes from birch-allergic patients.
    Casas R; Lindau C; Zetterström O; Duchén K
    Scand J Immunol; 2008 Sep; 68(3):351-61. PubMed ID: 18782262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blockade of interleukin-6 signaling suppresses experimental autoimmune uveoretinitis by the inhibition of inflammatory Th17 responses.
    Hohki S; Ohguro N; Haruta H; Nakai K; Terabe F; Serada S; Fujimoto M; Nomura S; Kawahata H; Kishimoto T; Naka T
    Exp Eye Res; 2010 Aug; 91(2):162-70. PubMed ID: 20420831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uveitogenicity is associated with a Th1-like lymphokine profile: cytokine-dependent modulation of early and committed effector T cells in experimental autoimmune uveitis.
    Xu H; Rizzo LV; Silver PB; Caspi RR
    Cell Immunol; 1997 May; 178(1):69-78. PubMed ID: 9184700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CCR5-deficient mice develop experimental autoimmune uveoretinitis in the context of a deviant effector response.
    Takeuchi A; Usui Y; Takeuchi M; Hattori T; Kezuka T; Suzuki J; Okunuki Y; Iwasaki T; Haino M; Matsushima K; Usui M
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3753-60. PubMed ID: 16186359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered expression of Th1-type chemokine receptor CXCR3 on CD4+ T cells in myasthenia gravis patients.
    Suzuki Y; Onodera H; Tago H; Saito R; Ohuchi M; Shimizu M; Matsumura Y; Kondo T; Yoshie O; Itoyama Y
    J Neuroimmunol; 2006 Mar; 172(1-2):166-74. PubMed ID: 16427705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T-cell suppression by programmed cell death 1 ligand 1 on retinal pigment epithelium during inflammatory conditions.
    Sugita S; Usui Y; Horie S; Futagami Y; Aburatani H; Okazaki T; Honjo T; Takeuchi M; Mochizuki M
    Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2862-70. PubMed ID: 19182257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.